Oropharyngeal myofunctional therapy for obstructive sleep apnea
Official title: RANDOMIZED CONTROLLED NON-INFERIORITY TRIAL TO ANALYZE THE EFFECTIVENESS OF OROPHARYNGEAL MYOFUNCTIONAL THERAPY IN MILD-MODERATE OBSTRUCTIVE SLEEP APNEA IN THE GENERAL POPULATION
Run by Instituto de Investigación Marqués de Valdecilla · NCT06681974 · Data updated 2026-11-12
This study tests if a 20-week exercise program using oropharyngeal myofunctional therapy can help people with mild to moderate obstructive sleep apnea breathe better while they sleep.
Quick facts
| Phase | Phase 3 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Instituto de Investigación Marqués de Valdecilla Academic / other |
| Locations | 1 site (Santander) |
| Status | Recruiting |
| Started | May 1, 2023 |
| Main results expected | May 1, 2024 |
| Study ends | December 1, 2024 |
| Registry record updated | November 14, 2024 |
| Trial ID | NCT06681974 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 70 with a diagnosis of mild to moderate obstructive sleep apnea who are not suitable for CPAP or other treatments.
✕Probably not a fit
Patients with severe obstructive sleep apnea, craniofacial malformations, or significant comorbidities may not benefit from this therapy.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial investigates the effectiveness of oropharyngeal myofunctional therapy (OMT) as a conservative treatment for patients with mild to moderate obstructive sleep apnea (OSA). Participants will be randomly assigned to either an intervention group, which will engage in a 20-week exercise program based on OMT, or a control group that will receive standard hygienic-dietary measures. The study aims to assess changes in the apnea-hypopnea index and other relevant variables through respiratory polygraphy before and after the intervention. The trial seeks to provide insights into the efficacy of OMT in improving OSA symptoms and overall patient health.
Why it matters
Potential benefit: If successful, this therapy could offer a non-invasive treatment option for patients with mild to moderate obstructive sleep apnea.
How similar studies have gone: Previous studies have shown promising results for similar conservative treatments in managing obstructive sleep apnea, suggesting potential for success in this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acceptance and signature of the informed consent * Diagnosis of OSA with mild-moderate AHI without criteria for treatment with CPAP and/or other treatments (DAM). * Patients who refused CPAP, were not candidates and/or refused DAM. * Age \> 18 years and \< 70 years Exclusion Criteria: * Craniofacial malformations. Severe developmental delay. Intellectual disability. * Diagnosis of neurodegenerative disease. * Limited tongue mobility/presence of ankyloglossia as well as Temporo-Mandibular Joint pathology. * Regular use of hypnotic medications * Bulbar pathologies * AHI of central origin above 50% of the total sleep time. * Obesity grade II or more. * Severe cardiovascular, neuromuscular or pulmonary pathology or chronic domiciliary oxygen use. Hypoventilation-obesity syndrome. * Refuse to participate in the clinical trial despite fulfilling the inclusion criteria and not presenting any exclusion criteria.
Where it's running
-
Hospital universitario Marques de Valdecilla
Santander, Spain Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Multimodal Deep Learning to Predict Sleep Apnea Severity from SpO2 and Ballistocardiography
Researchers are testing a smart-mattress-based method that uses SpO2 and ballistocardiography data to predict sleep apnea severity in adults undergoing overnight sleep study.
-
Nightly wearable monitoring with at-home submental electrical stimulation for sleep apnea
This pilot test checks whether wearing a ring sensor at night and doing a 4-week at-home submental electrical stimulation is feasible for adults with obstructive sleep apnea and looks at changes in sleep metrics.
-
Functional capacity and muscle function in adults with obstructive sleep apnea
This study tests how obstructive sleep apnea affects respiratory and peripheral muscle strength, endurance, and upper‑extremity function compared with healthy adults.
-
Transcutaneous Electrical Stimulation for Obstructive Sleep Apnea
This study tests whether applying gentle electrical stimulation to the throat muscles at night can reduce sleep apnea severity in adults with obstructive sleep apnea.
-
Physical activity habits and sleep/ breathing in obstructive sleep apnea
This study tests whether daily physical activity habits affect sleep quality and breathing measurements in people with obstructive sleep apnea who are on CPAP therapy.
-
CES-EES score and a wearable ring for diagnosing obstructive sleep apnea
This study tests whether the CES-EES clinical score and the Belun Ring wearable can accurately diagnose obstructive sleep apnea without in-lab polysomnography in adults referred for suspected OSA.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.